| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |